Tumor infiltrating mast cells determine oncogenic HIF-2 α-conferred immune evasion in clear cell renal cell carcinoma
ConclusionsHIF-2 α contributed to evasion of anti-tumor immunity via SCF secretion and subsequent recruitment of mast cells in ccRCC patients.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Genetics | Immunotherapy | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Stem Cell Therapy | Stem Cells